Biofilm is an assemblage of microorganisms enclosed in a matrix of extracellular materials such as polysaccharide, 1) and relates to bacterial virulence, pathogenesis, and environmental survival. Indeed, microorganisms existing in biofilm have remarkably high resistance to antibiotics and the immune system of a host's life. [2] [3] [4] [5] Therefore, investigation of the molecular mechanisms of biofilm formation and search for new substances counteracting such formation are becoming an attractive research area.
and relates to bacterial virulence, pathogenesis, and environmental survival. Indeed, microorganisms existing in biofilm have remarkably high resistance to antibiotics and the immune system of a host's life. [2] [3] [4] [5] Therefore, investigation of the molecular mechanisms of biofilm formation and search for new substances counteracting such formation are becoming an attractive research area.
Tuberculosis is one of the most common causes of morbidity and mortality in human immunodeficiency virus (HIV)-positive adults living in poverty. 6) Although the role of biofilm formation in the pathogenesis of Mycobacterium (M.) tuberculosis remains unclear, many species of Mycobacterium including M. tuberculosis are known to form biofilm. Several studies suggested that biofilm formation may play an important role in the pathogenesis of M. ulcerans as a causative agent of chronic skin ulcers and the virulence of M. avium subspecies paratuberculosis as a potent risk factor for Crohn's disease. 7, 8) In addition, it is speculated that novel molecular events and regulatory circuitries of biofilm formation would still exist in Mycobacterium species. For instance, the cell wall biosynthesis, especially biosynthesis of mycolic acids, is involved in the process of biofilm formation in M. smegmatis and M. tuberculosis. [9] [10] [11] On the other hand, the marine environment provides rich chemical and biological diversity and has been a source of potent drug leads. Bioactive compounds from marine organisms are also considered to be useful tools for identification of novel drug targets and biological functions in the cells and microorganisms. Our previous work focused on the discovery of anti-dormant mycobacterial substances from marine organisms, and we discovered several active compounds such as halicyclamines 12, 13) (marine spongean macrocyclic alkaloid) and trichoderins 14) (novel aminolipopeptides from a marine sponge-derived Trichoderma sp.).
On the basis of this background, we established a screening system searching for inhibitors of biofilm formation against Mycobacterium species. We rediscovered desferrioxamine E, a cyclic trihydroxamate siderophore, 15) from the culture of the marine-derived Actinomycete MS67 as an inhibitor of biofilm formation against M. smegmatis. In this paper, the selective inhibitory activity of biofilm formation and the action-mechanism of desferrioxamine E against Mycobacterium species are presented. Isolation of Desferrioxamine E The actinomycete MS67 was isolated from marine sediment collected from a depth of 50 m off Wakasa Gulf, Kyoto, Japan. The MS67 strain was cultured in rice medium containing artificial sea water (totally 600 g of unpolished rice and 1.2 l of artificial sea water) under a static condition at 30°C for 3 weeks. The culture was extracted by acetone and a mixed organic solvent of acetone-methanol-ethyl acetate (4 : 2 : 1) and the crude extract was partitioned into a water-2-butanone mixture. The 2-butanone soluble portion (5.4 g) was further partitioned with an n-hexane and 90% methanol mixture. On the guidance of bioassay, the 90% methanol soluble portion (4.2 g) was fractionated by silica gel column chromatography (eluted with CHCl 3 -MeOH) and HPLC [COSMOSIL Cholester column (Nacalai Tesque, Kyoto, Japan); eluted with MeOH-H 2 O containing 0.1% H 3 PO 4 ] to afford desferrioxamine E (54 mg) (Fig. 1) . Desferrioxamine E was identified by physico-chemical properties, FAB-MS, and 2D-NMR analysis. 16 ) Desferrioxamine E has been isolated as an antibiotic by Stoll et al.
MATERIALS AND METHODS

Materials
15)
Bacterial Culture Mycobacterium smegmatis mc 2 155 and Mycobacterium bovis BACILLE de CALMETTE et GUÉRIN (BCG) Pasteur were maintained and grown in Middlebrook 7H9 broth containing 10% OADC, 0.5% glycerol and 0.05% Tween 80. The M63 complete medium (2% glucose, 1.36% KH 2 PO 4 , 0.5% casamino acids, 0.2% ammonium sulfate, 0.1% glycerol, 0.025% MgSO 4 , 0.015% CaCl 2 and 0.00005% FeSO 4 ) was used to induce biofilm formation of M. smegmatis. 17) M. bovis BCG was cultured in Sauton's medium (6.0% glycerol, 0.4% L-asparagine, 0.2% citric acid, 0.05% KH 2 PO 4 , 0.05% MgSO 4 , 0.005% ferric ammonium citrate and 0.0001% ZnSO 4 ) to induce the biofilm formation.
10)
Determination of Anti-microbial Activity M63 complete medium and Sauton's medium, which were supplemented with 0.05% Tween 80 to inhibit biofilm formation physically, 18) were used to evaluate anti-microbial activity of desferrioxamine E against M. smegmatis and M. bovis BCG, respectively. M. smegmatis (1ϫ10 4 colony forming unit (CFU)/0.1 ml/well) or M. bovis BCG (1ϫ10 5 CFU/0.1 ml/ well) were inoculated in a 96-well plate, and then serially diluted samples were added. The bacteria were incubated at 37°C for 4 d (for M. smegmatis) or for 10 d (for M. bovis BCG). Determination of MIC value for anti-microbial activity was performed by the established MTT method.
12)
Determination of Anti-biofilm Formation Activity M. smegmatis (1ϫ10 5 CFU/0.1 ml/well) was inoculated into a polystyrene 96-well plate, and then serially diluted samples were added. The bacteria were incubated at 30°C for 4 d a under static condition which induced biofilm formation. The biofilm formation of M. bovis BCG was induced according to the previous report. 10) Briefly, the 0.5 ml suspension of M. bovis BCG (1ϫ10 5 CFU) was inoculated into polystyrene bottles containing 20 ml of Sauton's medium with or without a testing sample. The bottles were incubated at 37°C for 5 weeks without shaking. During this period, caps of the bottles were closed tightly for 3 weeks and then maintained loosely for the last 2 weeks. The minimum inhibitory concentration (MIC) value was expressed as the lowest concentration that inhibited visible biofilm formation. To search for selective inhibitors of biofilm formation, we selected testing samples, whose MIC values of anti-biofilm formation activity were lower than those of anti-microbial activity.
Effect of Iron Concentration on the Bacterial Growth The suspension of M. smegmatis (1ϫ10 7 CFU) was grown in 10 ml of M63 complete medium containing 0.05% Tween 80 and different concentrations of FeSO 4 at 37°C. A 100 ml portion was collected at each time point, and the serially diluted cultures were plated on the Middlebrook 7H10 agar to measure CFU. Number of colonies was counted after 3 d incubation.
Effect of Desferrioxamine E on the Anti-mycobacterial Activity of Isoniazid against M. smegmatis Forming Biofilm M. smegmatis (2ϫ10 6 CFU/2 ml/well in 48-well plates) was grown in the M63 complete medium supplemented with 0.05% Tween 80 inhibiting biofilm formation physically or the M63 complete medium inducing biofilm formation in the presence or absence of desferrioxamine E (10 mM). After 4 d incubation at 30°C, isoniazid (final 72 mM, 4ϫMIC against M. smegmatis) was added to each well. Tween 80 (final 0.2%) was added to each well at the indicated time point, and the culture was incubated for an additional 24 h at 4°C to separate bacilli from the biofilm. The culture was then transferred to a plastic test tube, and was centrifuged at 3500 rpm for 15 min. The bacilli were resuspended with the 10 ml of M63 complete medium containing 0.05% Tween 80. Then, the serially diluted suspension was plated on the Middlebrook 7H10 agar to measure CFU. Number of colonies was counted after 3 d of incubation. Data were shown as a logarithmic percentage based on the CFU of the isoniazid untreated culture.
Statistical Analysis Data are shown as meanϮS.E. Differences between the data sets were determined by Dunnett's test. A difference of pϽ0.05 was regarded as significant.
RESULTS AND DISCUSSION
Anti-biofilm Formation and Anti-microbial Activities of Desferrioxamine E against Mycobacterium Species
To investigate the selectivity of desferrioxamine E as an inhibitor of biofilm formation, its anti-biofilm formation and anti-microbial activities were evaluated using M. smegmatis and M. bovis BCG. As shown in Table 1 , desferrioxamine E inhibited the biofilm formation of M. smegmatis and M. bovis BCG with a MIC value of 10 mM, whereas its MIC value of anti-microbial activity was a concentration of more than 160 mM. In addition, no anti-microbial activity was observed against both M. smegmatis and M. bovis BCG in the 7H9 medium, which is a standard medium for testing antimicrobial activity against Mycobacterium species (data not shown).
Restorative Effect of Desferrioxamine E on the Antimicrobial Activity of Isoniazid against M. smegmatis by Inhibiting Biofilm Formation M. tuberculosis in the biofilm has shown a tolerance to isoniazid, the anti-tuberculosis drug.
10) Therefore, we next examined whether desferrioxamine E is able to restore the anti-microbial activity of isoniazid against M. smegmatis forming biofilm (Fig. 2) . M. smegmatis, which was inhibited biofilm formation physically by using the M63 complete medium containing 0.05% Tween 80, was sensitive to isoniazid, and the CFU of M. smegmatis decreased in a time dependent fashion. On the other hand, M. smegmatis in the biofilm showed a tolerance to isoniazid. The CFU of M. smegmatis, of which biofilm formation was inhibited by desferrioxamine E (10 mM), was decreased time dependently by 72 mM of isoniazid. These data indicated that desferrioxamine E was able to restore the anti-microbial activity of isoniazid against M. smegmatis by inhibiting biofilm formation.
Effect of Iron on the Anti-biofilm Formation Activity of Desferrioxamine E Desferrioxamine E is known to be a cyclic trihydroxamate siderophore consisting of three units of 5-succinylated-1-amino-5-hydroxyaminopentane, 16) and is able to release iron from the complex of chrome azurol Siron at 8 mM concentration. 19) On the other hand, recent studies indicated that the M. smegmatis with a mutation in the biosynthetic gene of the mycobacterial siderophore, exchelin, failed to form biofilm. 20) It was also reported that iron is an essential substance for biofilm formation of M. smegmatis. 20) From these observations, we speculated that desferrioxamine E takes iron from the medium to inhibit biofilm formation of M. smegmatis. To confirm this hypothesis, we next investigated the effect of iron concentration on the anti-biofilm formation activity of desferrioxamine E. As shown in Table 2 , the MIC value of the anti-biofilm formation activity of desferrioxamine E was 10 mM in the M63 complete medium containing 2 mM of FeSO 4 . Then, the M. smegmatis cultured in the iron deficient M63 complete medium was not able to form biofilm as reported before (Table 2) , while the iron at more than 0.5 mM concentration did not affect the biofilm formation (data not shown). On the other hand, the MIC value of the anti-biofilm formation activity of desferrioxamine E was increased to 5 mM when M. smegmatis was cultured in the M63 complete medium that reduced iron concentration to 0.5 mM. While, the effect of desferrioxamine E was attenuated by increasing iron concentration in the M63 complete medium (Table 2) . Furthermore, the iron concentration of the M63 complete medium did not affect the growth of M. smegmatis and the anti-microbial activity of desferrioxamine E against M. smegmatis (Table 2, Fig. 3 ). These data suggested that the anti-biofilm formation activity of desferrioxamine E might come from the depletion of iron in the medium.
In this paper, we proved the importance of iron for forming biofilm in Mycobacterium species by a mechanistic analysis of the anti-biofilm formation activity of desferrioxamine E. In the study of Pseudomonas aeruginosa causing cystic fibrosis, Greenberg's group reported that a higher level of iron is required for biofilm formation than is needed for growth. 21, 22) This evidence indicates that desferrioxamine E might be a possible lead of anti-biofilm formation drugs for P. aeruginosa as well as pathogenic Mycobacterium species. 
